{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:22:04Z","timestamp":1793827324645,"version":"4.6.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,15]],"date-time":"2015-03-15T00:00:00Z","timestamp":1426377600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1136-x","type":"journal-article","created":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T06:01:29Z","timestamp":1426312889000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Surface antigen expression on peripheral blood monocytes in women with gynecologic malignancies"],"prefix":"10.1186","volume":"15","author":[{"given":"Maciej","family":"J\u00f3\u017awik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osazee E","family":"Okungbowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Lipska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"J\u00f3\u017awik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena","family":"Smoktunowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Semczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"J\u00f3\u017awik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Radziwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,15]]},"reference":[{"key":"1136_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57\u201370.","journal-title":"Cell"},{"key":"1136_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539\u201345.","journal-title":"Lancet"},{"key":"1136_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/path.1027","volume":"196","author":"L Bingle","year":"2002","unstructured":"Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol. 2002;196:254\u201365.","journal-title":"J Pathol"},{"key":"1136_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrc1256","volume":"4","author":"JW Pollard","year":"2004","unstructured":"Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4:71\u20138.","journal-title":"Nat Rev Cancer"},{"key":"1136_CR5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1158\/0008-5472.CAN-05-4005","volume":"66","author":"CE Lewis","year":"2006","unstructured":"Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006;66:605\u201312.","journal-title":"Cancer Res"},{"key":"1136_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0065-2423(07)00008-X","volume":"45","author":"A Yuan","year":"2008","unstructured":"Yuan A, Chen JJ-W, Yang P-C. Pathophysiology of tumor-associated macrophages. Adv Clin Chem. 2008;45:199\u2013223.","journal-title":"Adv Clin Chem"},{"key":"1136_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.canlet.2008.03.028","volume":"267","author":"A Sica","year":"2008","unstructured":"Sica A, Allavena P, Mantovani A. Cancer related inflammation: the macrophage connection. Cancer Lett. 2008;267:204\u201315.","journal-title":"Cancer Lett"},{"key":"1136_CR8","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1189\/jlb.0905495","volume":"80","author":"AEM Dirkx","year":"2006","unstructured":"Dirkx AEM, oude Egbrink MGA, Wagstaff J, Griffioen AW. Monocyte\/macrophage infiltration in tumors: modulators of angiogenesis. J Leukoc Biol. 2006;80:1183\u201396.","journal-title":"J Leukoc Biol"},{"key":"1136_CR9","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood.V75.5.1037.1037","volume":"75","author":"MA Arnaout","year":"1990","unstructured":"Arnaout MA. Structure and function of the leukocyte adhesion molecules CD11\/CD18. Blood. 1990;75:1037\u201350.","journal-title":"Blood"},{"key":"1136_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/BF00202069","volume":"74","author":"A van de Stolpe","year":"1996","unstructured":"van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med. 1996;74:13\u201333.","journal-title":"J Mol Med"},{"key":"1136_CR11","first-page":"106","volume":"9","author":"C Golias","year":"2005","unstructured":"Golias C, Charalabopoulos A, Peschos D, Maritsi D, Charalabopoulos K, Batistatou A. Adhesion molecules in cancer invasion and metastasis. Hippokratia. 2005;9:106\u201314.","journal-title":"Hippokratia"},{"key":"1136_CR12","unstructured":"COPE - Horst Ibelgaufts\u2019 COPE: Cytokines & Cells Online Pathfinder Encyclopedia: http:\/\/www.copewithcytokines.de\/cope.cgi?key=CD16 - accessed in March 2006, and verified in May 2014."},{"key":"1136_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00262-008-0516-3","volume":"58","author":"H Cho","year":"2009","unstructured":"Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim YT, et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother. 2009;58:15\u201323.","journal-title":"Cancer Immunol Immunother"},{"key":"1136_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/13547500902777616","volume":"14","author":"H Cho","year":"2009","unstructured":"Cho H, Kim J-H. Multiplication of neutrophil and monocyte counts (MNM) as an easily obtainable tumour marker for cervical cancer. Biomarkers. 2009;14:161\u201370.","journal-title":"Biomarkers"},{"key":"1136_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-85014-1","volume-title":"WHO International Classification of Tumors: Histological typing of female genital tract tumours","author":"RE Scully","year":"1994","unstructured":"Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ. WHO International Classification of Tumors: Histological typing of female genital tract tumours. Berlin, Heidelberg, New York, London, Paris, Tokyo, Hong Kong, Barcelona, Budapest: Springer; 1994."},{"key":"1136_CR16","first-page":"444","volume-title":"Blaustein\u2019s Pathology of the Female Genital Tract","author":"RJ Kurman","year":"1995","unstructured":"Kurman RJ, Zaino RJ, Norris HJ. Microscopic Grading. In: Kurman RJ, editor. Blaustein\u2019s Pathology of the Female Genital Tract. Fourthth ed. New York, Berlin, Heidelberg, London, Paris, Tokyo, Hong Kong, Barcelona, Budapest: Springer; 1995. p. 444\u20137.","edition":"Fourth"},{"key":"1136_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","volume":"105","author":"S Pecorelli","year":"2009","unstructured":"Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103\u20134.","journal-title":"Int J Gynaecol Obstet"},{"key":"1136_CR18","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/0002-9378(90)90460-O","volume":"162","author":"FIGO","year":"1990","unstructured":"FIGO. Changes in gynecologic staging by the International Federation of Gynecology and Obstetrics. Am J Obstet Gynecol. 1990;162:610\u20131.","journal-title":"Am J Obstet Gynecol"},{"key":"1136_CR19","first-page":"1167","volume":"18","author":"PA De Jaco","year":"1989","unstructured":"De Jaco PA, Fridman WH, Teillaud JL. Facteur de n\u00e9crose tumorale \u03b1, interleukine 2, et IgG-BF III (CD 16). Evaluation des taux s\u00e9riques dans les cancers gyn\u00e9cologiques. [Tumor necrosis factor-alpha, interleukin 2 and IgG-BF III (CD 16). Evaluation of serum levels in gynecologic cancer.]. Presse Med. 1989;18:1167\u20138.","journal-title":"Presse Med"},{"key":"1136_CR20","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1097\/IGC.0b013e3182249273","volume":"22","author":"N Brooks","year":"2012","unstructured":"Brooks N, Stojanovska L, Grant P, Apostolopoulos V, McDonald CF, Pouniotis DS. Characterization of blood monocyte phenotype in patients with endometrial cancer. Int J Gynecol Cancer. 2012;22:1500\u20138.","journal-title":"Int J Gynecol Cancer"},{"key":"1136_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.18632\/oncotarget.478","volume":"3","author":"UK Scarlett","year":"2012","unstructured":"Scarlett UK, Conejo-Garcia JR. Double agents in the war on cancer: Leukocytes govern ovarian cancer progression. Oncotarget. 2012;3:226\u20137.","journal-title":"Oncotarget"},{"key":"1136_CR22","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1158\/1078-0432.CCR-05-2254","volume":"12","author":"IO Gordon","year":"2006","unstructured":"Gordon IO, Freedman RS. Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patients. Clin Cancer Res. 2006;12:1515\u201324.","journal-title":"Clin Cancer Res"},{"key":"1136_CR23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00262-007-0401-5","volume":"57","author":"RS Freedman","year":"2008","unstructured":"Freedman RS, Ma Q, Wang E, Gallardo ST, Gordon IO, Shin JW, et al. Migration deficit in monocyte-macrophages in human ovarian cancer. Cancer Immunol Immunother. 2008;57:635\u201345.","journal-title":"Cancer Immunol Immunother"},{"key":"1136_CR24","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.4049\/jimmunol.163.11.6251","volume":"163","author":"AE Loercher","year":"1999","unstructured":"Loercher AE, Nash MA, Kavanagh JJ, Platsoucas CD, Freedman RS. Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells. J Immunol. 1999;163:6251\u201360.","journal-title":"J Immunol"},{"key":"1136_CR25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ijc.25036","volume":"127","author":"K Ksi\u0105\u017cek","year":"2010","unstructured":"Ksi\u0105\u017cek K, Miku\u0142a-Pietrasik J, Catar R, Dworacki G, Winckiewicz M, Frydrychowicz M, et al. Oxidative stress-dependent increase in ICAM-1 expression promotes adhesion of colorectal and pancreatic cancers to the senescent peritoneal mesothelium. Int J Cancer. 2010;127:293\u2013303.","journal-title":"Int J Cancer"},{"key":"1136_CR26","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4049\/jimmunol.1000494","volume":"186","author":"P Zhang","year":"2011","unstructured":"Zhang P, Ozdemir T, Chung C-Y, Robertson GP, Dong C. Sequential binding of \u03b1v\u03b23 and ICAM-1 determines fibrin-mediated melanoma capture and stable adhesion to CD11b\/CD18 on neutrophils. J Immunol. 2011;186:242\u201354.","journal-title":"J Immunol"},{"key":"1136_CR27","doi-asserted-by":"publisher","first-page":"e79769","DOI":"10.1371\/journal.pone.0079769","volume":"8","author":"Y-F He","year":"2013","unstructured":"He Y-F, Zhang M-Y, Wu X, Sun X-J, Xu T, He Q-Z, et al. High MUC2 expression in ovarian cancer is inversely associated with the M1\/M2 ratio of tumor-associated macrophages and patient survival time. PLoS One. 2013;8:e79769.","journal-title":"PLoS One"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1136-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1136-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1136-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1136-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:01:41Z","timestamp":1747785701000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1136-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,15]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1136"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1136-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,15]]},"assertion":[{"value":"26 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"129"}}